Polar Capital’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-287,684
Closed -$19.1M 304
2019
Q2
$19.1M Buy
+287,684
New +$16.8M 0.17% 153
2018
Q3
Sell
-177,950
Closed -$10.3M 285
2018
Q2
$10.3M Sell
177,950
-673,750
-79% -$32.9M 0.06% 191
2018
Q1
$34.3M Buy
851,700
+115,254
+16% +$4.35M 0.35% 94
2017
Q4
$25.7M Buy
736,446
+124,946
+20% +$4.15M 0.26% 115
2017
Q3
$20.3M Buy
+611,500
New +$20M 0.23% 125

Other funds holding TDOC

Polar Capital's TDOC Position: Q3 2019 in Review

Polar Capital sold out of Teladoc Health (TDOC) in Q3 2019, closing a stake of 287,684 shares — an estimated $19.1M sold.

Polar Capital first reported a position in TDOC in Q3 2017 and held it in 5 quarters. The position peaked at $34.3M in Q1 2018. 378 funds tracked by Wall St. Rank hold TDOC as of Q3 2019.

  • Polar Capital reported no remaining Teladoc Health position as of Q3 2019 after selling out during the quarter.
  • Polar Capital sold 287,684 Teladoc Health shares in Q3 2019, an estimated $19.1M.
  • Polar Capital first reported a position in Teladoc Health in Q3 2017 and held it in 5 quarters.
  • Polar Capital's Teladoc Health position peaked at $34.3M in Q1 2018.
  • 378 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2019.

Based on Polar Capital's 13F filing for Q3 2019, filed 14 Nov 2019.